Figure 4. The hazard ratio (HR) of insulin receptor substrate‐1 (IRS‐1) by different genotypes of CYP2C19*2.
Model adjusted for clinical covariates, including age, previous myocardial infarction, hypertension, diabetes, smoking status, previous percutaneous coronary intervention, left ventricular ejection fraction, serum creatinine, low‐density lipoprotein, and diagnosis. * P value indicates the association between IRS‐1 genotypes and major adverse cardiovascular events in all patients.